Your browser doesn't support javascript.
loading
Risk Factors for Overdose in Young People Who Received Substance Use Disorder Treatment.
Yule, Amy M; Carrellas, Nicholas W; DiSalvo, Maura; Lyons, Rachael M; McKowen, James W; Nargiso, Jessica E; Bergman, Brandon G; Kelly, John F; Wilens, Timothy E.
Affiliation
  • Yule AM; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
  • Carrellas NW; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • DiSalvo M; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Lyons RM; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
  • McKowen JW; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
  • Nargiso JE; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
  • Bergman BG; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Kelly JF; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wilens TE; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Am J Addict ; 28(5): 382-389, 2019 09.
Article in En | MEDLINE | ID: mdl-31291042
ABSTRACT
BACKGROUND AND

OBJECTIVES:

To identify substance and psychiatric predictors of overdose (OD) in young people with substance use disorders (SUDs) who received treatment.

METHODS:

We conducted a retrospective review of consecutive medical records of young people who were evaluated in a SUD program between 2012 and 2013 and received treatment. An independent group of patients from the same program who received treatment and had a fatal OD were also included in the sample. OD was defined as substance use associated with a significant impairment in level of consciousness without intention of self-harm, or an ingestion of a substance that was reported as a suicide attempt. t Tests, Pearson's χ2 , and Fisher's exact tests were performed to identify predictors of OD after receiving treatment.

RESULTS:

After initial evaluation, 127 out of 200 patients followed up for treatment and were included in the sample. Ten (8%) of these patients had a nonfatal OD. Nine patients who received treatment and had a fatal OD were also identified. The sample's mean age was 20.2 ± 2.8 years. Compared with those without OD, those with OD were more likely to have a history of intravenous drug use (odds ratio [OR] 36.5, P < .001) and mood disorder not otherwise specified (OR 4.51, P = .01). DISCUSSION AND

CONCLUSIONS:

Intravenous drug use and mood dysregulation increased risk for OD in young people who received SUD treatment. SCIENTIFIC

SIGNIFICANCE:

It is important to identify clinically relevant risk factors for OD specific to young people in SUD treatment due to the risk for death associated with OD. (Am J Addict 2019;28382-389).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / Drug Overdose Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Am J Addict Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / Drug Overdose Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Am J Addict Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2019 Type: Article